Emergency coronary artery bypass grafting in non-ST-segment elevation acute coronary syndrome
https://doi.org/10.17802/2306-1278-2020-9-4-124-129
Abstract
This clinical case demonstrates the benefit of coronary artery bypass grafting as a method of revascularization in patients with high-risk non-ST-segment elevation acute coronary syndrome (NSTE ACS). Organizational measures set at the Research Institute for Complex Issues of Cardiovascular Diseases (the appointment of double antiplatelet therapy in patients with NSTE ACS after coronary angiography, Abstract the selection of treatment strategy and timing, the accessibility of coronary artery bypass grafting in 24/7 mode) allowed performing revascularization in the set timing recommended by current guidelines for myocardial revascularization. This case has shown that coronary artery bypass grafting is as effective as percutaneous coronary intervention in patients with high-risk NSTE ACS and multivessel coronary artery disease.
About the Authors
К. A. Kozyrin
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: заявляет об отсутствии конфликта интересов
Russian Federation
Kozyrin Kirill A. - M.D., Ph.D., a cardiovascular surgeon at the Cardiac Surgery Department.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: заявляет об отсутствии конфликта интересов
A. B. Nishonov
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: заявляет об отсутствии конфликта интересов
Russian Federation
Nishonov Aslidin B. - M.D., a Ph.D. student, laboratory assistant researcher at the Laboratory of Endovascular and Reconstructive Heart and Vessel Surgery, Department of Heart and Vessel Surgery.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: заявляет об отсутствии конфликта интересов
R. S. Tarasov
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: заявляет об отсутствии конфликта интересов
Russian Federation
Tarasov Roman S. - M.D., Ph.D., Head of the Laboratory of Endovascular and Reconstructive Heart and Vessel Surgery, Department of Heart and Vessel Surgery.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: заявляет об отсутствии конфликта интересов
References
1. Sousa-Uva M., Neumann F.J., Ahlsson A., Alfonso F., Banning A.P., Benedetto U. еt al. ESC/ EACTS Guidelines on myocardial revascularization 2018. Eur. J. Cardiothorac. Surg. 2018; 55: 4 - 90. doi: 10.1093/ejcts/ezy289
2. Kosyagin D.O., Zavyrilina P.N., Sedih D.Yu., Bykova I.S., Kashtalap V.V. Factors associated with delays in seeking medical care in myocardial infarction. Complex Issues of Cardiovascular Diseases. 2017;(3):104-112. (In Russian) https://doi.org/10.17802/2306-1278-2017-6-3-104-112
3. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.P., Falk V, Head S.J., Juni P., Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
4. Szummer K., Wallentin L., Lindhagen L., Alfredsson J., Erlinge D., Held C., James S., Kellerth T., Lindahl B., Ravn-Fischer A., Rydberg E., Yndigegn T., Jernberg T. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014. Eur Heart J. 2018 Nov 7;39(42):3766-3776. doi: 10.1093/eurheartj/ehy554.54
5. Kontsevaya A.V., Kalinina A.M., Koltunov I.E., Oganov R.G. Socio-economic damage by acute coronary syndrome in russian federation. Rational Pharmacotherapy in Cardiology. 2011;7(2):158-166. (In Russian) https://doi.org/10.20996/1819-6446-2011-7-2-158-166
6. Hannan E.L., Samadashvili Z., Walford G., Jacobs A.K., Stamato N.J., Venditti F.J., Holmes D.R. Jr., Sharma S., King S.B. 3rd. Staged vs. one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv 2013;6(1):12-20.
7. Stone G.W., Bertrand M., Colombo A., Dangas G., Farkouh M.E., Feit F., Lansky A.J., Lincoff A.M., Mehran R., Moses J.W., Ohman M., White H.D. Acute Catheterization and Urgent Intervention Triage strategy Y (ACUITY) trial: study design and rationale.Am Heart J. 2004 Nov;148(5):764-75. doi: 10.1016/j.ahj.2004.04.036
8. Porto I., Bolognese L., Dudek D., Goldstein P., Hamm C., Tanguay J.F., Ten Berg J., Widimsky P., Le Gall N., Zagar A.J., LeNarz L.A., Miller D., Montalescot G. ACCOAST Investigators. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy. JACC Cardiovasc Interv. 2016 May 9;9(9):897-907. doi:10.1016/j.jcin.2016.01.041
Review
For citations:
Kozyrin К.A., Nishonov A.B., Tarasov R.S. Emergency coronary artery bypass grafting in non-ST-segment elevation acute coronary syndrome. Complex Issues of Cardiovascular Diseases. 2020;9(4):124-129. (In Russ.) https://doi.org/10.17802/2306-1278-2020-9-4-124-129
Views:
1095
